Harvard Bioscience shareholders approve 1-for-10 reverse stock split to regain Nasdaq compliance

HARVARD BIOSCIENCE INC

Stockholders approved reverse stock split at March 6, 2026 special meeting; 27.0M votes for, 678K against.
Board set final ratio at 1-for-10; Charter amendment filed with Delaware Secretary of State.
Effective time 4:30 p.m. ET on March 13, 2026; split-adjusted trading begins March 16, 2026 under same symbol HBIO.
Outstanding shares reduced from ~44.7M to ~4.47M; authorized shares unchanged at 80M.
No fractional shares issued; stockholders entitled to cash payment in lieu based on closing price on March 13.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.